Table of Content

1 Transdermal Medical Patch Market Overview
1.1 Product Overview and Scope of Transdermal Medical Patch
1.2 Transdermal Medical Patch Segment by Type
1.2.1 Global Transdermal Medical Patch Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Methyl Salicylate-Based Patch
1.2.3 Rivastigmine Patch
1.2.4 Fentanyl Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Patch
1.2.8 Others
1.3 Transdermal Medical Patch Segment by Application
1.3.1 Transdermal Medical Patch Sales Comparison by Application: (2021-2027)
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Global Transdermal Medical Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Medical Patch Revenue 2016-2027
1.4.2 Global Transdermal Medical Patch Sales 2016-2027
1.4.3 Transdermal Medical Patch Market Size by Region: 2016 Versus 2021 Versus 2027

2 Transdermal Medical Patch Market Competition by Manufacturers
2.1 Global Transdermal Medical Patch Sales Market Share by Manufacturers (2016-2021)
2.2 Global Transdermal Medical Patch Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Transdermal Medical Patch Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Transdermal Medical Patch Manufacturing Sites, Area Served, Product Type
2.5 Transdermal Medical Patch Market Competitive Situation and Trends
2.5.1 Transdermal Medical Patch Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Transdermal Medical Patch Players Market Share by Revenue
2.5.3 Global Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Transdermal Medical Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Medical Patch Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Transdermal Medical Patch Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Transdermal Medical Patch Market Facts & Figures by Country
3.3.1 North America Transdermal Medical Patch Sales by Country
3.3.2 North America Transdermal Medical Patch Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transdermal Medical Patch Market Facts & Figures by Country
3.4.1 Europe Transdermal Medical Patch Sales by Country
3.4.2 Europe Transdermal Medical Patch Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transdermal Medical Patch Market Facts & Figures by Region
3.5.1 Asia Pacific Transdermal Medical Patch Sales by Region
3.5.2 Asia Pacific Transdermal Medical Patch Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transdermal Medical Patch Market Facts & Figures by Country
3.6.1 Latin America Transdermal Medical Patch Sales by Country
3.6.2 Latin America Transdermal Medical Patch Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Transdermal Medical Patch Market Facts & Figures by Country
3.7.1 Middle East and Africa Transdermal Medical Patch Sales by Country
3.7.2 Middle East and Africa Transdermal Medical Patch Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Transdermal Medical Patch Historic Market Analysis by Type
4.1 Global Transdermal Medical Patch Sales Market Share by Type (2016-2021)
4.2 Global Transdermal Medical Patch Revenue Market Share by Type (2016-2021)
4.3 Global Transdermal Medical Patch Price by Type (2016-2021)

5 Global Transdermal Medical Patch Historic Market Analysis by Application
5.1 Global Transdermal Medical Patch Sales Market Share by Application (2016-2021)
5.2 Global Transdermal Medical Patch Revenue Market Share by Application (2016-2021)
5.3 Global Transdermal Medical Patch Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hisamitsu Pharmaceutical Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 UCB Pharma Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Pharmaceutical Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.6.1 Nitto Denko Corporation Information
6.6.2 Nitto Denko Description and Business Overview
6.6.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nitto Denko Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Corporation Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Grünenthal Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.9.4 IBSA Group Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GSK Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Transdermal Medical Patch Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Luye Pharma Group Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Transdermal Medical Patch Description and Business Overview
6.12.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Pfizer Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Transdermal Medical Patch Description and Business Overview
6.13.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Chattem Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Corporation Information
6.14.2 Dr Reddy’s Laboratories Transdermal Medical Patch Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dr Reddy’s Laboratories Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Transdermal Medical Patch Description and Business Overview
6.15.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Bayer Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Corporation Information
6.16.2 Mundipharma Transdermal Medical Patch Description and Business Overview
6.16.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Mundipharma Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Corporation Information
6.17.2 Endo International Transdermal Medical Patch Description and Business Overview
6.17.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Endo International Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Corporation Information
6.18.2 Beijing Tide Pharmaceutical Transdermal Medical Patch Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Beijing Tide Pharmaceutical Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates

7 Transdermal Medical Patch Manufacturing Cost Analysis
7.1 Transdermal Medical Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transdermal Medical Patch
7.4 Transdermal Medical Patch Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transdermal Medical Patch Distributors List
8.3 Transdermal Medical Patch Customers

9 Transdermal Medical Patch Market Dynamics
9.1 Transdermal Medical Patch Industry Trends
9.2 Transdermal Medical Patch Growth Drivers
9.3 Transdermal Medical Patch Market Challenges
9.4 Transdermal Medical Patch Market Restraints

10 Global Market Forecast
10.1 Transdermal Medical Patch Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transdermal Medical Patch by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Transdermal Medical Patch by Type (2022-2027)
10.2 Transdermal Medical Patch Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transdermal Medical Patch by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Transdermal Medical Patch by Application (2022-2027)
10.3 Transdermal Medical Patch Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transdermal Medical Patch by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Transdermal Medical Patch by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Transdermal Medical Patch Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Transdermal Medical Patch Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Transdermal Medical Patch Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Transdermal Medical Patch Covered in This Study
Table 5. Global Transdermal Medical Patch Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Transdermal Medical Patch Sales Share by Manufacturers (2016-2021)
Table 7. Global Transdermal Medical Patch Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Transdermal Medical Patch Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Transdermal Medical Patch Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Transdermal Medical Patch Manufacturing Sites and Area Served
Table 11. Manufacturers Transdermal Medical Patch Product Type
Table 12. Global Transdermal Medical Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transdermal Medical Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Medical Patch as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Transdermal Medical Patch Sales by Region (2016-2021) & (K Units)
Table 16. Global Transdermal Medical Patch Sales Market Share by Region (2016-2021)
Table 17. Global Transdermal Medical Patch Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Transdermal Medical Patch Sales by Country (2016-2021) & (K Units)
Table 19. North America Transdermal Medical Patch Sales Market Share by Country (2016-2021)
Table 20. North America Transdermal Medical Patch Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Transdermal Medical Patch Revenue Market Share by Country (2016-2021)
Table 22. Europe Transdermal Medical Patch Sales by Country (2016-2021) & (K Units)
Table 23. Europe Transdermal Medical Patch Sales Market Share by Country (2016-2021)
Table 24. Europe Transdermal Medical Patch Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Transdermal Medical Patch Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Transdermal Medical Patch Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Transdermal Medical Patch Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Transdermal Medical Patch Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Transdermal Medical Patch Revenue Market Share by Region (2016-2021)
Table 30. Latin America Transdermal Medical Patch Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Transdermal Medical Patch Sales Market Share by Country (2016-2021)
Table 32. Latin America Transdermal Medical Patch Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Transdermal Medical Patch Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Transdermal Medical Patch Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Transdermal Medical Patch Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Transdermal Medical Patch Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Transdermal Medical Patch Revenue Market Share by Country (2016-2021)
Table 38. Global Transdermal Medical Patch Sales (K Units) by Type (2016-2021)
Table 39. Global Transdermal Medical Patch Sales Market Share by Type (2016-2021)
Table 40. Global Transdermal Medical Patch Revenue (Million US$) by Type (2016-2021)
Table 41. Global Transdermal Medical Patch Revenue Share by Type (2016-2021)
Table 42. Global Transdermal Medical Patch Price (US$/Unit) by Type (2016-2021)
Table 43. Global Transdermal Medical Patch Sales (K Units) by Application (2016-2021)
Table 44. Global Transdermal Medical Patch Sales Market Share by Application (2016-2021)
Table 45. Global Transdermal Medical Patch Revenue (Million US$) by Application (2016-2021)
Table 46. Global Transdermal Medical Patch Revenue Share by Application (2016-2021)
Table 47. Global Transdermal Medical Patch Price (US$/Unit) by Application (2016-2021)
Table 48. Hisamitsu Pharmaceutical Corporation Information
Table 49. Hisamitsu Pharmaceutical Description and Business Overview
Table 50. Hisamitsu Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Hisamitsu Pharmaceutical Transdermal Medical Patch Product
Table 52. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Business Overview
Table 55. Johnson & Johnson Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Johnson & Johnson Transdermal Medical Patch Product
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Novartis Transdermal Medical Patch Product
Table 62. Novartis Recent Developments/Updates
Table 63. UCB Pharma Corporation Information
Table 64. UCB Pharma Description and Business Overview
Table 65. UCB Pharma Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. UCB Pharma Transdermal Medical Patch Product
Table 67. UCB Pharma Recent Developments/Updates
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Business Overview
Table 70. Mylan Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Mylan Transdermal Medical Patch Product
Table 72. Mylan Recent Developments/Updates
Table 73. Teva Pharmaceutical Corporation Information
Table 74. Teva Pharmaceutical Description and Business Overview
Table 75. Teva Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Teva Pharmaceutical Transdermal Medical Patch Product
Table 77. Teva Pharmaceutical Recent Developments/Updates
Table 78. Nitto Denko Corporation Information
Table 79. Nitto Denko Description and Business Overview
Table 80. Nitto Denko Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Nitto Denko Transdermal Medical Patch Product
Table 82. Nitto Denko Recent Developments/Updates
Table 83. Grünenthal Corporation Information
Table 84. Grünenthal Description and Business Overview
Table 85. Grünenthal Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Grünenthal Transdermal Medical Patch Product
Table 87. Grünenthal Recent Developments/Updates
Table 88. IBSA Group Corporation Information
Table 89. IBSA Group Description and Business Overview
Table 90. IBSA Group Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. IBSA Group Transdermal Medical Patch Product
Table 92. IBSA Group Recent Developments/Updates
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. GSK Transdermal Medical Patch Product
Table 97. GSK Recent Developments/Updates
Table 98. Luye Pharma Group Corporation Information
Table 99. Luye Pharma Group Description and Business Overview
Table 100. Luye Pharma Group Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Luye Pharma Group Transdermal Medical Patch Product
Table 102. Luye Pharma Group Recent Developments/Updates
Table 103. Pfizer Corporation Information
Table 104. Pfizer Description and Business Overview
Table 105. Pfizer Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Pfizer Transdermal Medical Patch Product
Table 107. Pfizer Recent Developments/Updates
Table 108. Chattem Corporation Information
Table 109. Chattem Description and Business Overview
Table 110. Chattem Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Chattem Transdermal Medical Patch Product
Table 112. Chattem Recent Developments/Updates
Table 113. Dr Reddy’s Laboratories Corporation Information
Table 114. Dr Reddy’s Laboratories Description and Business Overview
Table 115. Dr Reddy’s Laboratories Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Dr Reddy’s Laboratories Transdermal Medical Patch Product
Table 117. Dr Reddy’s Laboratories Recent Developments/Updates
Table 118. Bayer Corporation Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Bayer Transdermal Medical Patch Product
Table 122. Bayer Recent Developments/Updates
Table 123. Mundipharma Corporation Information
Table 124. Mundipharma Description and Business Overview
Table 125. Mundipharma Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Mundipharma Transdermal Medical Patch Product
Table 127. Mundipharma Recent Developments/Updates
Table 128. Endo International Corporation Information
Table 129. Endo International Description and Business Overview
Table 130. Endo International Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Endo International Transdermal Medical Patch Product
Table 132. Endo International Recent Developments/Updates
Table 133. Beijing Tide Pharmaceutical Corporation Information
Table 134. Beijing Tide Pharmaceutical Description and Business Overview
Table 135. Beijing Tide Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Beijing Tide Pharmaceutical Transdermal Medical Patch Product
Table 137. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Transdermal Medical Patch Distributors List
Table 141. Transdermal Medical Patch Customers List
Table 142. Transdermal Medical Patch Market Trends
Table 143. Transdermal Medical Patch Growth Drivers
Table 144. Transdermal Medical Patch Market Restraints
Table 145. Global Transdermal Medical Patch Sales Forecast by Type (2022-2027) & (K Units)
Table 146. Global Transdermal Medical Patch Sales Market Share Forecast by Type (2022-2027)
Table 147. Global Transdermal Medical Patch Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 148. Global Transdermal Medical Patch Revenue Market Share Forecast by Type (2022-2027)
Table 149. Global Transdermal Medical Patch Sales Forecast by Application (2022-2027) & (K Units)
Table 150. Global Transdermal Medical Patch Sales Market Share Forecast by Application (2022-2027)
Table 151. Global Transdermal Medical Patch Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 152. Global Transdermal Medical Patch Revenue Market Share Forecast by Application (2022-2027)
Table 153. Global Transdermal Medical Patch Sales Forecast by Region (2022-2027) & (K Units)
Table 154. Global Transdermal Medical Patch Sales Market Share Forecast by Region (2022-2027)
Table 155. Global Transdermal Medical Patch Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 156. Global Transdermal Medical Patch Revenue Market Share Forecast by Region (2022-2027)
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transdermal Medical Patch
Figure 2. Global Transdermal Medical Patch Market Share by Type in 2020 & 2027
Figure 3. Methyl Salicylate-Based Patch Product Picture
Figure 4. Rivastigmine Patch Product Picture
Figure 5. Fentanyl Patch Product Picture
Figure 6. Lidocaine Patch Product Picture
Figure 7. Diclofenac Patch Product Picture
Figure 8. Nicotine Patch Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transdermal Medical Patch Market Share by Application in 2020 & 2027
Figure 11. Offline Channel
Figure 12. Online Channel
Figure 13. Global Transdermal Medical Patch Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Transdermal Medical Patch Market Size 2016-2027 (US$ Million)
Figure 15. Global Transdermal Medical Patch Sales 2016-2027 (K Units)
Figure 16. Global Transdermal Medical Patch Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Transdermal Medical Patch Sales Share by Manufacturers in 2020
Figure 18. Global Transdermal Medical Patch Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Transdermal Medical Patch Players: Market Share by Revenue in 2020
Figure 20. Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Transdermal Medical Patch Sales Market Share by Region (2016-2021)
Figure 22. Global Transdermal Medical Patch Sales Market Share by Region in 2020
Figure 23. Global Transdermal Medical Patch Revenue Market Share by Region (2016-2021)
Figure 24. Global Transdermal Medical Patch Revenue Market Share by Region in 2020
Figure 25. U.S. Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Transdermal Medical Patch Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Transdermal Medical Patch by Type (2016-2021)
Figure 50. Sales Market Share of Transdermal Medical Patch by Application (2016-2021)
Figure 51. Sales Market Share of Transdermal Medical Patch by Application in 2020
Figure 52. Revenue Share of Transdermal Medical Patch by Application (2016-2021)
Figure 53. Revenue Share of Transdermal Medical Patch by Application in 2020
Figure 54. Manufacturing Cost Structure of Transdermal Medical Patch
Figure 55. Manufacturing Process Analysis of Transdermal Medical Patch
Figure 56. Transdermal Medical Patch Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed